142
72. Rogatsch H, Hittmair A, Reissigl A, et al. Microvessel density in core biopsies of prostatic
adenocarcinoma: a stage predictor? J Pathol 1997; 182:205-210.
73. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. In Collaboration with Sobin LH
and Pathologists from 14 countries. World Health Organization International Histological
typing of lung and pleural tumours. Histological typing of lung and pleural tumours. 3
rd
Ed.
Springer-Verlag, 1999.
74. Fontanini G, Vignati S, Bigini D, et al. Neoangiogenesis: a putative marker of malignancy in
non-small-cell lung cancer (NSCLC) development. Int J Cancer 1996; 67(5):615-619.
75. Hansen S, Sorensen FB, Vach W, et al. Microvessel density compared with the Chalkley count
in a prognostic study of angiogenesis in breast cancer patients. Histopathology 2004; 44:428-
436.
76. Weidner N. Tumor angiogenesis: Review of current applications in tumor prognostication.
Semin Diag Pathol 1993; 10:302-313.
77. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human
tumours: an international consensus on the methodology and criteria of evaluation. Eur J
Cancer 1996; 32A:2474-2484.
78. Giatromanolaki A. Prognostic role of angiogenesis in non-small cell lung cancer. Anticancer
Res 2001; 21:4373-82.
79. Fox SB, Leek RD, Weekes MP, et al. Quantitation and prognostic value of breast cancer
angiogenesis: comparison of microvessel density, Chalkley count, and computer image
analysis. J Pathol 1995; 177:275-283.
80. Benoy IH, Salgado R, Elst H, et al. Relative microvessel area of the primary tumour, and not
lymph node status, predicts the presence of bone marrow micrometastasis detected by reverse
transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
Breast Cancer Res 2005; 7:R210-R219.
81. Hansen S, Grabau D, Sorensen F, et al. The prognostic value of angiogenesis by Chalkley
counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 2000;
6:139-146.
82. Speck N, Focchi J, Alves A, Osório C, Bacarat E. Relação entre angiogênese e o estádio do
carcinoma de endométrio. Rev Bras Ginecol Obstet 2003; 25:396-401.
83. Blatt RJ, Clark NA, Courtney J, et al. Automated quantitative analysis of angiogenesis in the
rat aorta model using Image-Pro Plus 4.1. Comput Methods Programs Biomed 2004; 75:75-79.
84. Padubidri A, Browne EJ. Effect of vascular endothelial growth factors (VEGF) on survival of
random extension of axial pattern skin flaps in the rat. Ann Plast Surg 1996; 37:604-611.
85. Carai A, Diaz G, Santa Cruz R, Santa Cruz G. Computerized quantitative color analysis for
histological study of pulmonary fibrosis. Anticancer Res 2002; 22:3889-3894.
86. Goddard JC, Sutton, Furness PN, et al. A computer image analysis system for microvessel
density measurement in solid tumours. Angiogenesis 2002; 5:15-20.
87. Korkolopoulou P, Patsouris E, Kavantzas N, et al. Prognostic implications of microvessel
morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol 2002; 28:57-66.
88. Korkolopoulou P, Konstantinidou AE, Kavantzas N, et al. Morphometric microvascular
characteristics predict prognosis in superficial and invasive baldder cancer. Virchows Arch
2001; 438:603-611.
89. Mehaffey MG, Folberg R, Meyer M, et al. Relative importance of quantifying area and
vascular patterns in uveal melanomas. Am J Ophthalmol 1997; 123:798-809.
90. Marson LP, Kurian KM, Miller WR, Dixon JM. Reproducibility of microvessel counts in
breast cancer specimens. Br J Cancer 1999; 81:1088-1093.
91. Matsuyama K, Chiba Y, Sasaki M, et al. Tumor angiogenesis as a prognostic marker in
operable non-small cell lung cancer. Ann Thorac Surg 1998; 65:1405-1409.
92. Yamazaki K, Abe S, Takekawa H, et al. Tumor angiogenesis in human lung andecarcinoma.
Cancer 1994(8); 74:2245-2250.
93. Yuan A, Yang PC, Yu CJ, et al. Tumor angiogenesis correlates with histologic type and
metastasis in non-small-cell lung cancer. Am J Respir Crit Care Med 1995; 152:2157-2162.